Concord Medical Services Holdings Ltd

$CCM Market Cap: $22.11 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$756.6M

TTM

Gross Margin

-31.36%

TTM

Net Earnings

-$580.6M

TTM

Current Assets

$86.93M

Q4 2023

Current Liabilities

$274.8M

Q4 2023

Current Ratio

31.63%

Q4 2023

Total Assets

$852.7M

Q4 2023

Total Liabilities

$606.6M

Q4 2023

Book Value

$246.1M

Q4 2023

Cash

$8.189M

Q4 2023

P/E

-0.03807

Nov 29, 2024 EST

Free Cash Flow

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue	$75.69M	$68.45M	$485.6M	$223.0M	$198.4M	$190.9M	$331.0M	$455.0M	$616.5M	$606.9M	$563.1M	$455.7M	$450.1M	$389.5M	$292.4M	$171.8M	$81.40M
YoY Change	10.58%	-85.9%	117.76%	12.4%	3.93%	-42.33%	-27.25%	-26.2%	1.58%	7.78%	23.57%	1.24%	15.56%	33.21%	70.2%	111.06%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue	$75.69M	$68.45M	$485.6M	$223.0M	$198.4M	$190.9M	$331.0M	$455.0M	$616.5M	$606.9M	$563.1M	$455.7M	$450.1M	$389.5M	$292.4M	$171.8M	$81.40M
Cost Of Revenue	$86.48M	$90.54M	$542.5M	$209.9M	$214.2M	$171.1M	$233.0M	$286.5M	$353.3M	$274.6M	$217.7M	$164.5M	$159.4M	$122.7M	$87.60M	$45.60M	$24.30M
Gross Profit	-$10.79M	-$22.10M	-$56.90M	$13.10M	-$15.80M	$19.80M	$98.00M	$168.5M	$263.1M	$332.3M	$345.5M	$291.1M	$290.7M	$266.8M	$204.8M	$126.2M	$57.10M
Gross Profit Margin	-14.26%	-32.28%	-11.72%	5.87%	-7.96%	10.37%	29.61%	37.03%	42.68%	54.75%	61.36%	63.88%	64.59%	68.5%	70.04%	73.46%	70.15%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Selling, General & Admin	$54.42M	$54.03M	$401.4M	$320.6M	$345.4M	$313.6M	$281.3M	$276.0M	$245.8M	$148.7M	$189.2M	$107.8M	$118.1M	$83.90M	$37.50M	$24.40M	$68.00M
YoY Change	0.73%	-86.54%	25.2%	-7.18%	10.14%	11.48%	1.92%	12.29%	65.3%	-21.41%	75.51%	-8.72%	40.76%	123.73%	53.69%	-64.12%
% of Gross Profit				2447.33%		1583.84%	287.04%	163.8%	93.42%	44.75%	54.76%	37.03%	40.63%	31.45%	18.31%	19.33%	119.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.57M	$12.86M	$104.1M	$80.30M	$56.40M	$54.70M	$94.70M	$129.1M	$158.4M	$201.7M	$182.5M	$150.2M	$120.6M	$109.7M	$78.20M	$38.10M	$21.00M
YoY Change	-10.05%	-87.65%	29.64%	42.38%	3.11%	-42.24%	-26.65%	-18.5%	-21.47%	10.52%	21.5%	24.54%	9.94%	40.28%	105.25%	81.43%
% of Gross Profit				612.98%		276.26%	96.63%	76.62%	60.21%	60.7%	52.82%	51.6%	41.49%	41.12%	38.18%	30.19%	36.78%
Operating Expenses	$54.42M	$54.03M	$401.5M	$320.6M	$345.4M	$313.6M	$281.2M	$276.1M	$245.8M	$148.6M	$189.1M	$107.8M	$118.1M	$84.00M	$37.50M	$24.40M	$68.00M
YoY Change	0.73%	-86.54%	25.23%	-7.18%	10.14%	11.52%	1.85%	12.33%	65.41%	-21.42%	75.42%	-8.72%	40.6%	124.0%	53.69%	-64.12%
Operating Profit	-$65.21M	-$76.13M	-$458.4M	-$307.5M	-$361.2M	-$293.8M	-$183.2M	-$107.6M	$17.30M	$183.7M	$156.4M	$183.3M	$172.6M	$182.8M	$167.3M	$101.8M	-$10.90M
YoY Change	-14.34%	-83.39%	49.07%	-14.87%	22.94%	60.37%	70.26%	-721.97%	-90.58%	17.46%	-14.68%	6.2%	-5.58%	9.26%	64.34%	-1033.94%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Interest Expense	$23.33M	$17.45M	-$69.70M	-$117.7M	$10.40M	$31.70M	-$72.40M	-$46.50M	$7.700M	-$6.200M	-$12.80M	-$4.900M	-$4.100M	-$5.000M	-$6.200M	-$7.400M	-$1.200M
YoY Change	33.72%	-125.04%	-40.78%	-1231.73%	-67.19%	-143.78%	55.7%	-703.9%	-224.19%	-51.56%	161.22%	19.51%	-18.0%	-19.35%	-16.22%	516.67%
% of Operating Profit									44.51%	-3.38%	-8.18%	-2.67%	-2.38%	-2.74%	-3.71%	-7.27%
Other Income/Expense, Net	-$1.527M	-$31.41M	-$1.200M	$6.300M	$37.10M	$34.20M	$2.900M	$18.20M	$33.60M	$2.100M	$2.000M	-$300.0K	$300.0K	-$400.0K	$0.00	$7.300M	-$300.0K
YoY Change	-95.14%	2517.08%	-119.05%	-83.02%	8.48%	1079.31%	-84.07%	-45.83%	1500.0%	5.0%	-766.67%	-200.0%	-175.0%		-100.0%	-2533.33%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Pretax Income	$78.26M	$121.8M	-$529.2M	-$441.7M	-$391.1M	-$225.2M	-$253.9M	-$204.6M	-$5.300M	$175.6M	$144.3M	$182.5M	-$165.0M	$174.8M	$161.2M	$102.4M	-$14.10M
YoY Change	-35.74%	-123.01%	19.81%	12.94%	73.67%	-11.3%	24.1%	3760.38%	-103.02%	21.69%	-20.93%	-210.61%	-194.39%	8.44%	57.42%	-826.24%
Income Tax	-$3.461M	-$10.28M	-$6.600M	-$37.60M	-$39.00M	$34.10M	$31.80M	$60.50M	$74.00M	$80.90M	$63.80M	$54.20M	$46.30M	$43.90M	$36.40M	$23.30M	$14.80M
% Of Pretax Income	-4.42%	-8.44%								46.07%	44.21%	29.7%		25.11%	22.58%	22.75%
Net Earnings	-$41.93M	-$70.99M	-$271.4M	-$310.0M	-$307.0M	-$234.9M	-$284.3M	-$261.9M	-$80.30M	$124.7M	$85.90M	$132.2M	-$215.0M	$129.4M	$124.8M	$79.10M	-$28.90M
YoY Change	-40.94%	-73.84%	-12.45%	0.98%	30.69%	-17.38%	8.55%	226.15%	-164.39%	45.17%	-35.02%	-161.49%	-266.15%	3.69%	57.77%	-373.7%
Net Earnings / Revenue	-55.39%	-103.72%	-55.89%	-139.01%	-154.74%	-123.05%	-85.89%	-57.56%	-13.03%	20.55%	15.25%	29.01%	-47.77%	33.22%	42.68%	46.04%	-35.5%
Basic Earnings Per Share	-$0.32	-$0.54	-$6.26	-$5.11
Diluted Earnings Per Share	-$0.32	-$0.54	-$2.070M	-$2.365M	-$2.358M	-$1.806M	-$2.185M	-$2.005M	-$597.0K	$922.3K	$635.8K	$956.6K	-$1.511M	$886.3K	$1.673M	$1.376M	-$578.0K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Cash & Short-Term Investments	$158.3M	$160.1M	$359.3M	$109.5M	$484.4M	$117.1M	$249.0M	$646.4M	$622.5M	$411.8M	$164.8M	$369.4M	$555.3M	$1.037B	$354.0M	$39.80M
YoY Change	-1.13%	-55.44%	228.13%	-77.39%	313.66%	-52.97%	-61.48%	3.84%	51.17%	149.88%	-55.39%	-33.48%	-46.46%	192.99%	789.45%
Cash & Equivalents	$158.3M	$157.4M	$334.3M	$74.30M	$404.7M	$98.20M	$189.9M	$485.4M	$478.7M	$283.0M	$75.40M	$219.1M	$535.8M	$1.037B	$354.0M	$39.80M
Short-Term Investments	$0.00	$2.700M	$25.00M	$35.20M	$79.60M	$18.90M	$59.10M	$161.0M	$143.9M	$128.8M	$89.50M	$150.3M	$19.50M	$0.00
Other Short-Term Assets	$399.7M	$269.4M	$225.6M	$96.30M	$663.6M	$850.0M	$718.0M	$604.8M	$556.5M	$532.0M	$445.8M	$105.1M	$161.4M	$85.90M	$43.70M	$5.100M
YoY Change	48.38%	19.41%	134.27%	-85.49%	-21.93%	18.38%	18.72%	8.68%	4.61%	19.34%	324.17%	-34.88%	87.89%	96.57%	756.86%
Inventory	$84.84M	$38.10M	$21.60M	$4.300M	$3.400M	$6.300M	$5.900M	$3.900M	$3.000M	$19.70M	$8.700M
Prepaid Expenses
Receivables	$130.3M	$127.9M	$77.40M	$73.70M	$86.90M	$132.0M	$189.6M	$218.3M	$265.0M	$313.9M	$210.3M	$244.2M	$169.4M	$111.3M	$92.80M	$19.00M
Other Receivables	-$13.32M	-$11.00M	-$7.900M	-$1.400M	-$9.500M	$5.800M	$32.40M	$27.70M	$16.70M	$22.50M	$23.60M	$15.00M	$18.30M	$18.10M	$2.500M	$2.200M
Total Short-Term Assets	$759.8M	$584.5M	$676.0M	$282.5M	$1.229B	$1.111B	$1.195B	$1.501B	$1.464B	$1.300B	$853.1M	$733.7M	$904.4M	$1.253B	$493.0M	$66.10M
YoY Change	29.99%	-13.54%	139.29%	-77.01%	10.58%	-7.01%	-20.4%	2.56%	12.59%	52.39%	16.27%	-18.87%	-27.79%	154.06%	645.84%
Property, Plant & Equipment	$3.854B	$3.765B	$3.199B	$2.546B	$1.219B	$793.6M	$775.3M	$918.8M	$749.7M	$1.493B	$1.523B	$1.267B	$1.102B	$667.6M	$349.1M	$54.70M
YoY Change	2.38%	17.67%	25.66%	108.8%	53.64%	2.36%	-15.62%	22.56%	-49.77%	-1.99%	20.24%	14.91%	65.11%	91.23%	538.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$437.9M	$395.4M	$326.7M	$92.00M	$431.3M	$808.4M	$259.4M	$362.1M	$352.1M	$416.9M	$402.1M	$97.80M	$66.40M	$0.00
YoY Change	10.74%	21.03%	255.11%	-78.67%	-46.65%	211.64%	-28.36%	2.84%	-15.54%	3.68%	311.15%	47.29%
Other Assets	$24.03M	$245.8M	$396.2M	$634.1M	$645.7M	$296.6M	$540.0M	$338.4M	$281.1M	$334.2M	$357.5M	$139.0M	$115.6M	$68.30M	$190.3M	$32.90M
YoY Change	-90.23%	-37.96%	-37.52%	-1.8%	117.7%	-45.07%	59.57%	20.38%	-15.89%	-6.52%	157.19%	20.24%	69.25%	-64.11%	478.42%
Total Long-Term Assets	$5.245B	$5.646B	$4.659B	$4.015B	$3.357B	$2.354B	$2.034B	$2.093B	$1.496B	$2.794B	$2.812B	$1.660B	$1.759B	$1.191B	$1.021B	$476.9M
YoY Change	-7.09%	21.19%	16.03%	19.61%	42.58%	15.76%	-2.81%	39.91%	-46.46%	-0.66%	69.43%	-5.62%	47.61%	16.64%	114.17%
Total Assets	$6.005B	$6.230B	$5.335B	$4.297B	$4.585B	$3.465B	$3.229B	$3.594B	$2.959B	$4.094B	$3.665B	$2.393B	$2.663B	$2.444B	$1.514B	$543.0M
YoY Change
Accounts Payable	$146.7M	$102.5M	$18.60M	$8.300M	$5.400M	$4.600M	$2.000M	$800.0K	$1.100M	$152.4M	$106.5M	$2.200M	$10.30M	$11.30M	$13.30M	$43.70M
YoY Change	43.17%	451.08%	124.1%	53.7%	17.39%	130.0%	150.0%	-27.27%	-99.28%	43.1%	4740.91%	-78.64%	-8.85%	-15.04%	-69.57%
Accrued Expenses	$355.0M	$321.6M	$198.6M	$187.7M	$226.5M	$155.7M	$100.9M	$64.30M	$71.70M	$146.1M	$101.1M	$43.50M	$35.90M	$36.80M	$23.80M	$27.00M
YoY Change	10.38%	61.93%	5.81%	-17.13%	45.47%	54.31%	56.92%	-10.32%	-50.92%	44.51%	132.41%	21.17%	-2.45%	54.62%	-11.85%
Deferred Revenue
YoY Change
Short-Term Debt	$168.6M	$136.5M	$24.50M	$285.5M	$396.5M	$597.3M	$642.0M	$649.6M	$322.1M	$488.8M	$383.1M	$15.00M	$83.00M	$11.50M	$20.80M	$0.00
YoY Change	23.52%	457.14%	-91.42%	-27.99%	-33.62%	-6.96%	-1.17%	101.68%	-34.1%	27.59%	2454.0%	-81.93%	621.74%	-44.71%
Long-Term Debt Due	$344.0M	$162.8M	$124.4M	$42.90M	$44.10M	$197.1M	$82.60M	$350.8M	$246.2M	$273.3M	$193.6M	$81.10M	$64.50M	$61.10M	$43.60M	$5.700M
YoY Change	111.29%	30.87%	189.98%	-2.72%	-77.63%	138.62%	-76.45%	42.49%	-9.92%	41.17%	138.72%	25.74%	5.56%	40.14%	664.91%
Total Short-Term Liabilities	$1.121B	$804.5M	$512.1M	$627.5M	$870.3M	$1.108B	$951.1M	$1.507B	$769.8M	$1.175B	$859.5M	$216.7M	$269.2M	$169.6M	$190.5M	$88.40M
YoY Change	39.37%	57.1%	-18.39%	-27.9%	-21.47%	16.52%	-36.9%	95.79%	-34.47%	36.67%	296.63%	-19.5%	58.73%	-10.97%	115.5%
Long-Term Debt	$2.471B	$2.179B	$1.968B	$1.292B	$497.5M	$448.1M	$464.3M	$598.8M	$335.5M	$325.0M	$301.3M	$111.0M	$50.40M	$89.00M	$63.80M	$38.50M
YoY Change	13.44%	10.7%	52.35%	159.66%	11.02%	-3.49%	-22.46%	78.48%	3.23%	7.87%	171.44%	120.24%	-43.37%	39.5%	65.71%
Other Long-Term Liabilities	$284.0M	$318.7M	$300.2M	$323.6M	$343.9M	$424.4M	$531.8M	$3.000M	$3.700M	$127.3M	$128.8M	$8.800M	$14.20M	$6.200M	$9.500M	$5.500M
YoY Change	-10.88%	6.16%	-7.23%	-5.9%	-18.97%	-20.2%	17626.67%	-18.92%	-97.09%	-1.16%	1363.64%	-38.03%	129.03%	-34.74%	72.73%
Total Long-Term Liabilities	$2.755B	$2.497B	$2.268B	$1.615B	$841.4M	$872.5M	$996.1M	$601.8M	$339.2M	$452.3M	$430.1M	$119.8M	$64.60M	$95.20M	$73.30M	$44.00M
YoY Change	10.34%	10.1%	40.41%	91.99%	-3.56%	-12.41%	65.52%	77.42%	-25.01%	5.16%	259.02%	85.45%	-32.14%	29.88%	66.59%
Total Liabilities	$7.869B	$7.600B	$5.998B	$4.420B	$4.148B	$2.531B	$2.062B	$2.202B	$1.162B	$1.972B	$1.634B	$458.9M	$458.0M	$290.1M	$283.9M	$148.1M
YoY Change	3.54%	26.72%	35.68%	6.56%	63.87%	22.74%	-6.34%	89.54%	-41.07%	20.69%	255.98%	0.2%	57.88%	2.18%	91.69%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	131.1M	131.1M	131.1M	131.1M
Diluted Shares Outstanding	131.1M	131.1M	131.1M	131.1M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $22.108 Million

About Concord Medical Services Holdings Ltd

Concord Medical Services Holdings Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Beijing, Beijing and currently employs 727 full-time employees. The company went IPO on 2009-12-11. Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The firm operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The firm mainly conducts its business in the domestic market.

Industry: Services-Offices & Clinics of Doctors of Medicine Peers: QDM International Inc. Aesthetic Medical International Holdings Group Ltd